July 17, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

Conexiant

July 14, 2026

Oversight May Be Critical in Patient Acceptance of AI in Radiology

A UK survey found that patients supported AI as a clinical tool but wanted physicians to remain responsible for medical decisions.

Conexiant

July 13, 2026

Does Pediatric Readiness Reduce ED Imaging?

Hospitals with stronger pediatric emergency capability used less imaging overall, but differences by insurance status and race and ethnicity remained.

Conexiant

July 02, 2026

Simplified Bone Age Method May Aid Review

Single-bone approach showed close agreement with Greulich-Pyle assessments in adolescents, particularly among experienced raters

Conexiant

June 26, 2026

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

June 26, 2026

ASE Plenary: Progress, Priorities, and What’s Next

Efforts to align, sustain, and engage drove a year of growth for ASE.

Conexiant

June 24, 2026

No Short-Term Brain Changes in Youth Soccer

Researchers tracked cognitive, behavioral, imaging, and biomarker outcomes in 129 adolescent athletes across one season.

Conexiant

June 18, 2026

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Conexiant

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Conexiant

May 20, 2026

Medical Oddities: Something Viral is Lurking in the Dust

Everyday things like yawns, tea, dust, and kimchi suddenly look medically important.

Conexiant